MGTA - Magenta Therapeutics EPS beats by $0.06 August, 06 2020 09:07 AM Magenta Therapeutics Inc. Magenta Therapeutics (NASDAQ:MGTA): Q2 GAAP EPS of -$0.48 beats by $0.06.Cash, cash equivalents and marketable securities of $176.5MPress ReleaseMore news on: Magenta Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,